Xcout Intel
GRAYBUG VISION, INC.
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
Subscribe to see GRAYBUG VISION, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GRAYBUG VISION, INC. at a glance
GRAYBUG VISION, INC. is a biotechnology company headquartered in United States. It has raised at least $99.5M across the 2 funding rounds on record. Its most recent funding round raised $55M in July 2019. Xcout tracks 1 named person at GRAYBUG VISION, INC., including Nguyễn Văn Chung (Chịu trách nhiệm nội dung).
GRAYBUG VISION, INC. leadership
- Nguyễn Văn ChungChịu trách nhiệm nội dung
GRAYBUG VISION, INC. funding rounds
At least $99.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $55M | — | |
| Series B | $44.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
GRAYBUG VISION, INC. competitors
A few of GRAYBUG VISION, INC.'s closest competitors — see the full list of competitors and alternatives →
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Broadwing Bio is a biotechnology company that develops antibody-based therapies to treat major causes of adult vision loss, specifically focusing on Geographic Atrophy and Glaucoma. The company utilizes genetics-driven insights to target ocular diseases and preserve vision for patients.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Stargazer Pharmaceuticals, Inc. is a Boston-based biopharmaceutical company focused on developing novel treatments for rare eye diseases, including Stargardt disease. The company advances clinical-stage pharmaceutical candidates through specialized clinical trials.
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Memento Medicines, Inc. is a privately held biotechnology company headquartered in Boston, Massachusetts, focused on developing novel biologic therapies for retinal diseases.
Get GRAYBUG VISION, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GRAYBUG VISION, INC. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access